Abner Herrman & Brock’s Sanofi SNY Stock Holding History

Abner Herrman & Brock’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-4,946	Closed	-$205K	–	121
2016 Q2	$205K	Sell	4,946 -430	-8%	-$17.6K	0.05%	113
2016 Q1	$216K	Buy	+5,376	New	+$216K	0.05%	105
2014 Q4	–	Sell	-5,008	Closed	-$283K	–	100
2014 Q3	$283K	Hold	5,008	–	–	0.08%	87
2014 Q2	$266K	Hold	5,008	–	–	0.08%	92
2014 Q1	$262K	Buy	+5,008	New	+$254K	0.08%	89

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Abner Herrman & Brock's SNY Position: Q3 2016 in Review

Abner Herrman & Brock sold out of Sanofi (SNY) in Q3 2016, closing a stake of 4,946 shares — an estimated $205K sold.

Abner Herrman & Brock first reported a position in SNY in Q1 2014 and held it in 5 quarters. The position peaked at $283K in Q3 2014. 450 funds tracked by Wall St. Rank hold SNY as of Q3 2016.

Abner Herrman & Brock reported no remaining Sanofi position as of Q3 2016 after selling out during the quarter.
Abner Herrman & Brock sold 4,946 Sanofi shares in Q3 2016, an estimated $205K.
Abner Herrman & Brock first reported a position in Sanofi in Q1 2014 and held it in 5 quarters.
Abner Herrman & Brock's Sanofi position peaked at $283K in Q3 2014.
450 funds tracked by Wall St. Rank held Sanofi as of Q3 2016.

Based on Abner Herrman & Brock's 13F filing for Q3 2016, filed 3 Nov 2016.